Explain this page
Arphra AIPlain-English read on EyePoint Pharmaceuticals, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$0.93
-93.53% vs spot
Recommendation
Sell
5 of 5 methods
Method spread
0bull5bear
±5% threshold
Analyst PT consensus: $37.50 (+160.42%)
Candlestick · 1Y
Open in chart workstation →EYPT
13.58+2.18%H 18.87L 11.30MA50 13.33MA200 —Avg vol 1.3M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.14% | +5.73% | +11.37% | +14.38% | -21.14% | -21.18% | +56.86% | +105.71% | +51.26% | -53.25% | -96.41% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$14.40
69 sh
Bid
$13.30
2,000 sh
Ask
$15.25
200 sh
Spread
$1.950
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $620K | -$67.61M | $-0.81 |
| Q3 Sep 2025 | $966K | -$59.73M | $-0.85 |
| Q2 Jun 2025 | $5.33M | -$59.43M | $-0.85 |
| Q1 Mar 2025 | $24.45M | -$45.2M | $-0.65 |
| Q4 Dec 2024 | $11.59M | -$41.4M | $-0.64 |
| Q3 Sep 2024 | $10.52M | -$29.36M | $-0.54 |
Sector & industry today
LiveSectors
- Real Estate+1.26%
- Utilities+0.96%
- Consumer Cyclical+0.94%
- Energy+0.84%
- Financial Services+0.65%
- Basic Materials-0.11%
- Communication Services-0.40%
- Healthcare-0.41%
- Industrials-0.47%
- Technology-0.80%
- Consumer Defensive-1.00%
Top industries (issuer's industry highlighted)
- Biotechnology+6.56%
- Financial - Mortgages-4.05%
- Home Improvement+3.89%
- Electrical Equipment & Parts+3.88%
- Paper, Lumber & Forest Products+3.53%
- Software - Services-3.30%
- Software - Infrastructure-3.07%
- Financial - Conglomerates+2.62%
- Auto - Dealerships+2.54%
- Luxury Goods+2.47%
- Auto - Recreational Vehicles+2.22%
- REIT - Industrial-2.20%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)globenewswire.com·Jun 16, 2026
- EyePoint, Inc. (EYPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 09, 2026
- EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developmentsglobenewswire.com·May 06, 2026
Peers
No peer list available for EYPT.
Total assets
$364M
Total debt
$20.77M
Cash & equiv
$101.82M
Operating CF
-$240.11M
Free cash flow
-$243.39M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $31.37M | -$243.43M | -$231.96M | $-3.17 | -739.42% |
| FY 2024 | $43.27M | -$145.85M | -$130.87M | $-2.32 | -302.43% |
| FY 2023 | $46.02M | -$75.07M | -$70.8M | $-1.82 | -153.84% |
| FY 2022 | $41.4M | -$99.64M | -$102.25M | $-2.74 | -246.97% |
| FY 2021 | $36.94M | -$55.28M | -$58.42M | $-2.03 | -158.14% |